MICHAEL W BEVERS to Drug Resistance, Multiple
This is a "connection" page, showing publications MICHAEL W BEVERS has written about Drug Resistance, Multiple.
Connection Strength
0.010
-
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Ann N Y Acad Sci. 2000; 922:349-51.
Score: 0.010